ReviewCancers2023

Hematological Adverse Events with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Systematic Review with Meta-Analysis.

Olivia Kronick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.